Trust Asset Management’s Quest Diagnostics DGX Stock Holding History

Trust Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Hold	1,238	–	–	0.02%	208
2026 Q1	$243K	Hold	1,238	–	–	0.02%	205
2025 Q4	$215K	Sell	1,238 -44	-3%	-$8.01K	0.01%	219
2025 Q3	$244K	Hold	1,282	–	–	0.02%	211
2025 Q2	$230K	Hold	1,282	–	–	0.02%	215
2025 Q1	$217K	Buy	+1,282	New	+$211K	0.02%	208
2023 Q1	–	Sell	-1,326	Closed	-$207K	–	207
2022 Q4	$207K	Buy	+1,326	New	+$191K	0.03%	194
2022 Q1	–	Sell	-1,288	Closed	-$223K	–	202
2021 Q4	$223K	Buy	+1,288	New	+$196K	0.03%	193

Other funds holding DGX

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

JWM

JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Trust Asset Management's DGX Position: Q2 2026 in Review

Trust Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,238 shares worth $262K. The position accounts for 0.02% of the portfolio, ranked #208.

Trust Asset Management first reported a position in DGX in Q4 2021 and has held it in 8 quarters since. 210 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Trust Asset Management held 1,238 shares of Quest Diagnostics worth $262K as of Q2 2026.
Trust Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.02% of Trust Asset Management's portfolio in Q2 2026, its #208 holding.
Trust Asset Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 8 quarters since.
210 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.